Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancer.

Although immunotherapy holds significant promise for treating drug-resistant cancers, currently available procedures are rarely curative. A new type of cell-mediated immunotherapy based on anticancer targeting activated mismatched cancer killer cells (ATACK) has demonstrated better efficacy and curative potential in preclinical animal models and in a pilot compassionate clinical study.